BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24946737)

  • 1. Atypical fibroxanthoma: a series of 56 tumors and an unexplained uneven distribution of cases in southeast Germany.
    Wollina U; Schönlebe J; Ziemer M; Friedling F; Koch A; Haroske G; Kaatz M; Simon JC
    Head Neck; 2015 Jun; 37(6):829-34. PubMed ID: 24946737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?
    Ang GC; Roenigk RK; Otley CC; Kim Phillips P; Weaver AL
    Dermatol Surg; 2009 May; 35(5):765-72. PubMed ID: 19389106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with mohs micrographic surgery.
    Seavolt M; McCall M
    Dermatol Surg; 2006 Mar; 32(3):435-41; discussion 439-41. PubMed ID: 16640694
    [No Abstract]   [Full Text] [Related]  

  • 4. A retrospective analysis of atypical fibroxanthoma treated with Mohs micrographic surgery at a single academic institution.
    Matsumoto A; Brown Z; Matsumoto M; Vandergriff T; Srivastava D; Nijhawan RI
    J Am Acad Dermatol; 2021 Mar; 84(3):794-796. PubMed ID: 32497695
    [No Abstract]   [Full Text] [Related]  

  • 5. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Atypical Fibroxanthoma Versus Malignant Fibrous Histiocytoma.
    Branch LG; Albertini JG; Leshin B
    J Craniofac Surg; 2015 Jun; 26(4):e322-3. PubMed ID: 26080249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized cutaneous metastases from an atypical fibroxanthoma.
    Giuffrida TJ; Kligora CJ; Goldstein GD
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Fibroxanthoma: The Washington University Experience.
    Phelan PS; Rosman IS; Council ML
    Dermatol Surg; 2019 Dec; 45(12):1450-1458. PubMed ID: 30939522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma.
    Davis JL; Randle HW; Zalla MJ; Roenigk RK; Brodland DG
    Dermatol Surg; 1997 Feb; 23(2):105-10. PubMed ID: 9107284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
    Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
    Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural Invasion in Atypical Fibroxanthoma of the Scalp and Forehead.
    Fosko SW; Ghahramani GK; Slutksy JB; Macdonald JB; Butler ST; Hurley MY
    Dermatol Surg; 2015 Sep; 41(9):1073-6. PubMed ID: 26262947
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent atypical fibroxanthoma of the cheek.
    Skoulas IG; Price M; Andrew JE; Kountakis SE
    Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
    Ly H; Selva D; James CL; Huilgol SC
    Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.
    Tolkachjov SN; Kelley BF; Alahdab F; Erwin PJ; Brewer JD
    J Am Acad Dermatol; 2018 Nov; 79(5):929-934.e6. PubMed ID: 29981390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fibroxanthoma.
    Hakim I
    Ann Otol Rhinol Laryngol; 2001 Oct; 110(10):985-7. PubMed ID: 11642435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mohs surgery vs wide excision for atypical fibroxanthoma: follow-up.
    Zalla MJ; Randle HW; Brodland DG; Davis JL; Roenigk RK
    Dermatol Surg; 1997 Dec; 23(12):1223-4. PubMed ID: 9426678
    [No Abstract]   [Full Text] [Related]  

  • 17. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
    Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
    J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year analysis of cutaneous mesenchymal tumors (sarcomas and related entities) in a skin cancer center.
    Wollina U; Koch A; Hansel G; Schönlebe J; Kittner T; Pabst F; Haroske G; Nowak A
    Int J Dermatol; 2013 Oct; 52(10):1189-97. PubMed ID: 23829640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosquamous carcinoma of the skin: a case series.
    Fu JM; McCalmont T; Yu SS
    Arch Dermatol; 2009 Oct; 145(10):1152-8. PubMed ID: 19841403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residents'corner October 2015. Seriously saRComa!: Atypical fibroxanthoma.
    Behle V; Kneitz H; Goebeler M
    Eur J Dermatol; 2015; 25(5):520-1. PubMed ID: 26693640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.